# Peter S. Hammerman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-s-hammerman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,443 |
| Field | RNA modifications and cancer |
| h-index | 74 |
| i10-index | 113 |
| Last Known Institution | Casma Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5004171995 |
| ORCID iD | https://orcid.org/0009-0006-9143-899X |
| Works | 671 |

## Researcher papers

- [Comprehensive genomic characterization of squamous cell lung cancers](https://scholariq.org/papers/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/)
- [Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing](https://scholariq.org/papers/mapping-the-hallmarks-of-lung-adenocarcinoma-with-massively-parallel-sequencing/)
- [Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints](https://scholariq.org/papers/adaptive-resistance-to-therapeutic-pd-1-blockade-is-associated-with-upregulation/)
- [Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors](https://scholariq.org/papers/activation-of-the-pd-1-pathway-contributes-to-immune-escape-in-egfr-driven-lung/)
- [Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors](https://scholariq.org/papers/genomic-correlates-of-response-to-immune-checkpoint-blockade-in-microsatellite/)
- [<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression](https://scholariq.org/papers/i-met-i-exon-14-mutations-in-non-small-cell-lung-cancer-are-associated-with/)
- [STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment](https://scholariq.org/papers/stk11-lkb1-deficiency-promotes-neutrophil-recruitment-and-proinflammatory/)
- [Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers](https://scholariq.org/papers/frequent-mutation-of-the-pi3k-pathway-in-head-and-neck-cancer-defines-predictive/)
- [Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer](https://scholariq.org/papers/mutations-in-the-i-ddr2-i-kinase-gene-identify-a-novel-therapeutic-target-in/)
- [Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression](https://scholariq.org/papers/loss-of-lkb1-and-pten-leads-to-lung-squamous-cell-carcinoma-with-elevated-pd-l1/)
- [Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes](https://scholariq.org/papers/genomic-analysis-of-nasopharyngeal-carcinoma-reveals-tme-based-subtypes/)

## Researcher topics

- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Casma Therapeutics (United States)](https://scholariq.org/institutions/casma-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.